Safety and efficacy of treatment with vitamin K antagonists in patients managed in a network of anticoagulation services or as routine general care. Bleeding, Thrombosis and Vascular Biology, [S. l.], v. 1, n. 1, 2022. DOI: 10.4081/btvb.2022.9. Disponível em: https://www.btvb.org/btvb/article/view/9. Acesso em: 9 may. 2025.